Navigation Links
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
Date:11/13/2008

ANNAPOLIS, Md., Nov. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September 30, 2008.

For the third quarter of 2008, PharmAthene recognized revenues of $10.7 million compared to $3.4 million in the same period of 2007. For the nine months ended September 30, 2008 and 2007, the Company reported revenues of $27.4 million and $8.7 million, respectively. These revenues consisted primarily of contract funding from the U.S. government for the development of the Company's medical countermeasures, Protexia(R), SparVax(TM) and RypVax(TM). As a result of the Avecia vaccines acquisition in the second quarter of 2008, and particularly the acquired U.S. government contracts supporting the development of the rPA anthrax vaccines and RypVax(TM) plague vaccine product candidates, revenues for the three and nine month periods ended September 30, 2008 were further boosted by $5.5 million and $8.9 million, respectively.

Research and development expenses were $9.4 million and $3.6 million for the quarter ended September 30, 2008 and 2007, respectively. For the nine months ended September 30, 2008 and 2007, research and development expenses were $26.5 million and $10.7 million, respectively. Expenses for the third quarter and nine months of 2008 resulted from research and development activities related to programs for Valortim(R) and Protexia(R) as well as expenses related to the Company's SparVax(TM) and RypVax(TM) programs, which were acquired in the second quarter of 2008. The increase in research and development expenses is primarily due to process development expenses, manufacturing activities and clinical development expenses related to the Company's programs.

General and administrative expenses for the Company were $4.8 million and $3.2 m
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008
2. PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
3. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
4. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
5. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
6. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
7. PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008
8. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
9. PharmAthene Reports Second Quarter 2008 Financial and Operational Results
10. Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene
11. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... 2009 -- Esco announces the opening of a NEW 2nd North ... technical service, training and logistics center to support Esco,s growth in ... Introductions (NPI) for temperature-controlled laboratory equipment. , ... Hatboro, ... a NEW 2nd North American facility in Marietta, OH. The facility ...
(Date:12/10/2009)... National Institutes of Health (NIH), awarded a $2.18 million grant ... non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. ... ... (PRWEB) December 10, 2009 -- The National Eye Institute (NEI), ... a $2.18 million grant to Aciont Inc. to help fund ...
(Date:12/10/2009)... of advanced flow measurement, control, and level solutions, ... as Global Level Product Manager effective November 30, ... enhance market penetration of the level measurement products ... from Lafarge Corp, a manufacturer of building materials, ... Sales. Bayda will report to Brooks Instrument Vice ...
(Date:12/10/2009)... Dec. 10 Biomatrica, the leader in ... release of SampleWare 3.1 software system for laboratory ... latest release now includes an audit trail functionality ... a more complete history of any stored sample. ... feature offers customers a much needed ability to ...
Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3
... (NYSE: CRY ),a biomaterials, medical device and tissue ... 2007 financial results will be,released on Thursday, February 21, ... webcast at 10:00 a.m. Eastern Time, February,21, 2008, to ... session,hosted by Steven G. Anderson, president and chief executive ...
... help doctors and clinicians identify best ... risk of heart disease, BIRMINGHAM, Ala., Jan. 31 ... point to the need for more,detailed cholesterol testing, including ... Atherotech, a cardio-diagnostic company that,has developed an expanded cholesterol ...
... Fourth Quarter Worldwide Net Revenue Increased 10% to $5.8 Billion, and Reported Diluted Earnings ... Items, Increased 18% to ... $0.78, - 2007 Full Year Worldwide Net Revenue Increased ... Diluted, Earnings per Share, Before Certain Significant Items, Increased 12% to ...
Other Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 2Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 4Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 5Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 6Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 7Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 8Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 9Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 10Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 11Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 12Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 13Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 14Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 15
(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Horizontal string trimmer reduces labor costs, increases peach size 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 1Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 2Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 3Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 1Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 2Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 1Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 2
... can lead to urinary tract infections in women, according ... that UTIs may be caused by ingesting food contaminated ... Gastroenteric Disease Center. Previously, this link was not established, ... University of California-Berkeley, found that E.coli strains isolated from ...
... in forests between Gabon and the Republic of Congo ... according to a study by the Wildlife Conservation Society ... edition of the journal Emerging Infectious Diseases, the study ... 2001 and 2003 produced positive results, and found direct ...
... research indicates that it may all come down to ... scientists who had previously identified a key gene essential ... shows that this gene's function appears to be evolutionarily ... Leslie Vosshall's laboratory had previously shown that of 62 ...
Other Biology News:Bacteria collection sheds light on urinary tract infections 2Study Links Ebola Outbreaks To Animal Carcasses 2Ancient olfaction protein is shared by many bugs, offering new pest control target 2
... Complete kit for stabilizing 400g of purified ... optimised for the stabilization of aqueous RNA ... methods such as guanidine, phenol/chloroform, silica, oligo ... StabMRT Kits contain all the necessary components ...
... template is designed to allow kanamycin/neomycin selection ... It combines a prokaryotic promoter (gb2) for ... with a eukaryotic promoter (PGK) for ... The prokaryotic promoter gb2 is a ...
... culture flask is designed for culturing organisms requiring ... can also be used in serum production. Triple ... maximal oxygen transfer to culture medium. Beaded neck ... plugs or No. 13 rubber stoppers. This flask ...
... 30 isolations. The kit provides a simple ... cells from normal c lture using annexin ... a Ca2+-dependent phospholipid binding protein with high ... Isolation Kit provides a simple and efficient ...
Biology Products: